Matches in Wikidata for { <http://www.wikidata.org/entity/Q82088393> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q82088393 description "article scientifique (publié 2006)" @default.
- Q82088393 description "artikull shkencor i botuar më 01 janar 2006" @default.
- Q82088393 description "artículu científicu espublizáu en xineru de 2006" @default.
- Q82088393 description "scientific article published on 01 January 2006" @default.
- Q82088393 description "wetenschappelijk artikel" @default.
- Q82088393 description "наукова стаття, опублікована в січні 2006" @default.
- Q82088393 name "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 name "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 name "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 type Item @default.
- Q82088393 label "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 label "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 label "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 prefLabel "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 prefLabel "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 prefLabel "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 P1433 Q82088393-32C8F57A-7A76-4D48-99B5-100C7B701CD2 @default.
- Q82088393 P1476 Q82088393-1693B30A-478B-4894-ACD4-ADC422C41083 @default.
- Q82088393 P2093 Q82088393-03360D5C-4571-4DD7-AAC1-4EF3A451FC4C @default.
- Q82088393 P2093 Q82088393-171EA403-17DA-452A-8126-C6C0D52EAEA8 @default.
- Q82088393 P2093 Q82088393-18D41E20-6734-4C02-93B0-0127A60DBF59 @default.
- Q82088393 P2093 Q82088393-3FCB1854-DFD7-4D5F-AC8D-6B603EAB5313 @default.
- Q82088393 P2093 Q82088393-5CAD485F-87F6-4660-B22B-7C222AEF84DD @default.
- Q82088393 P2093 Q82088393-6E57D3FE-0405-4067-ADCB-67CEFA32B339 @default.
- Q82088393 P2093 Q82088393-7A0427DE-6B1F-4AA8-BF62-267B6A254FF7 @default.
- Q82088393 P2093 Q82088393-7D4884D2-605E-4238-BA1C-7DE1CE3EA31B @default.
- Q82088393 P2093 Q82088393-C150FD5E-5916-457C-BCF0-C3D0FBFF19EC @default.
- Q82088393 P2093 Q82088393-E99FCDD3-33ED-4764-8D3E-C2143793C301 @default.
- Q82088393 P2860 Q82088393-2E000B4D-5D95-42DA-B1F6-4E1D27D0FD74 @default.
- Q82088393 P2860 Q82088393-49368DEA-3AB0-478E-A00E-C86A33824306 @default.
- Q82088393 P2860 Q82088393-65B4F107-7E23-4536-B8BC-53ED4915C14A @default.
- Q82088393 P2860 Q82088393-6D243B6D-3585-485B-9D76-4BE1A332EB85 @default.
- Q82088393 P2860 Q82088393-7EE9C5B0-C43E-439B-B99F-F9C7176251BF @default.
- Q82088393 P2860 Q82088393-8DA1646E-EFD0-4FC2-AE39-85D414C7FB08 @default.
- Q82088393 P2860 Q82088393-9324055A-F751-44C9-BB63-26BE47EF2555 @default.
- Q82088393 P2860 Q82088393-BDE340F2-4D12-47C7-9132-BC24BCE4B787 @default.
- Q82088393 P2860 Q82088393-CBA6164D-E780-430D-A179-147604E15AB0 @default.
- Q82088393 P2860 Q82088393-EB3085A8-C348-453F-ADC8-8AC98F0566A5 @default.
- Q82088393 P2888 Q82088393-C3DDB7B8-A94E-4DCB-ABBA-67334BC71C5C @default.
- Q82088393 P304 Q82088393-E087FD53-9233-471C-8EE1-F274B9C6E4F7 @default.
- Q82088393 P31 Q82088393-44A3BCA9-D403-4909-8111-7E6151F2FD3B @default.
- Q82088393 P356 Q82088393-2DC87529-85A2-4F9E-9710-0C1ADB56BD5A @default.
- Q82088393 P433 Q82088393-7F82A06F-DECA-4C0C-8CE3-19E9E6E41518 @default.
- Q82088393 P478 Q82088393-DD4807DA-6D62-4487-AEB9-BD597BD9B3B8 @default.
- Q82088393 P577 Q82088393-A0F69CB7-0EFC-42FF-8223-D7CDFBEB439F @default.
- Q82088393 P6179 Q82088393-91CDAA8A-AC73-476D-8755-E1828C595659 @default.
- Q82088393 P698 Q82088393-C0ABAF6E-A868-4C42-BFAD-36A296B3A0BA @default.
- Q82088393 P921 Q82088393-4E4C98A8-A20E-4DFA-818F-F20D14F9FCC0 @default.
- Q82088393 P356 S10637-005-4544-Y @default.
- Q82088393 P698 16379038 @default.
- Q82088393 P1433 Q2312231 @default.
- Q82088393 P1476 "A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma" @default.
- Q82088393 P2093 "Francis Ruvuna" @default.
- Q82088393 P2093 "Jeffrey S Weber" @default.
- Q82088393 P2093 "John A Thompson" @default.
- Q82088393 P2093 "Jose Lutzky" @default.
- Q82088393 P2093 "Karl D Lewis" @default.
- Q82088393 P2093 "Rene Gonzalez" @default.
- Q82088393 P2093 "Sewa S Legha" @default.
- Q82088393 P2093 "Simon Floret" @default.
- Q82088393 P2093 "Steven O'Day" @default.
- Q82088393 P2093 "William A Robinson" @default.
- Q82088393 P2860 Q28374384 @default.
- Q82088393 P2860 Q28378420 @default.
- Q82088393 P2860 Q29620739 @default.
- Q82088393 P2860 Q34187304 @default.
- Q82088393 P2860 Q35063945 @default.
- Q82088393 P2860 Q35146577 @default.
- Q82088393 P2860 Q35146582 @default.
- Q82088393 P2860 Q35826366 @default.
- Q82088393 P2860 Q40452730 @default.
- Q82088393 P2860 Q44894031 @default.
- Q82088393 P2888 s10637-005-4544-y @default.
- Q82088393 P304 "89-94" @default.
- Q82088393 P31 Q13442814 @default.
- Q82088393 P356 "10.1007/S10637-005-4544-Y" @default.
- Q82088393 P433 "1" @default.
- Q82088393 P478 "24" @default.
- Q82088393 P577 "2006-01-01T00:00:00Z" @default.
- Q82088393 P6179 "1000257176" @default.
- Q82088393 P698 "16379038" @default.
- Q82088393 P921 Q42824440 @default.